Publications by authors named "Craig Vargo"

Claim this Profile
T
The Immunomodulatory Effects of Dexamethasone on Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer.
Kai Conrad Cecil Johnson, Daniel Goldstein, Jasmin Tharakan, Dionisia Quiroga, Mahmoud Kassem, Craig Vargo

Oncol Ther· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomechanical effect of neurologic dance training (NDT) for breast cancer survivors with chemotherapy-induced neuropathy: study protocol for a randomized controlled trial and preliminary baseline data.
Kristen Lantis, Patrick Schnell, Courtney R Bland, Jacqueline Wilder, Karen Hock, Craig Vargo

Trials· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Concurrent Proton Pump Inhibitors With Palbociclib Tablets for Metastatic Breast Cancer.
Timothy Schieber, Samantha Steele, Stephanie Collins, Michael Berger, Megan Fleming, Craig Vargo

Clin Breast Cancer· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacy utilization of electronic patient-reported outcomes in oncology populations.
Lauren M Aschermann, Michael Berger, Craig Vargo, Stephanie Collins, Julie Kennerly-Shah

J Oncol Pharm Pract· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Dose Intensity on Pathologic Complete Response Rate in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Docetaxel, Carboplatin, Trastuzumab and Pertuzumab (TCHP).
Dat Le, Craig Vargo, Stephanie Collins, Nicole Williams, Marilly Palettas

Target Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of subsequent infusion hypersensitivity reactions to paclitaxel using two different infusion strategies.
Kristen Nymberg, Stephanie Folan, Michael Berger, Junan Li, Kyle Zanath, Craig Vargo

Support Care Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience.
Anupama Suresh, Akannsha Ganju, Evan Morgan, Marilly Palettas, Julie A Stephens, Craig Vargo

Invest New Drugs· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience.
Christina M Matthews, Kristen Nymberg, Michael Berger, Craig A Vargo, Jessica Dempsey

J Oncol Pharm Pract· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer.
Jonathan Wilkie, M Alexandra Schickli, Michael J Berger, Maryam Lustberg, Raquel Reinbolt, Craig A Vargo

Clin Breast Cancer· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time to treatment failure of palbociclib and letrozole as second-line therapy or beyond in hormone receptor-positive advanced breast cancer.
M Alexandra Schickli, Michael J Berger, Maryam Lustberg, Marilly Palettas, Craig A Vargo

J Oncol Pharm Pract· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of dose-reduced pemetrexed in patients with renal insufficiency.
Jordan Hill, Craig Vargo, Michael Smith, Jessica Streeter, David P Carbone

J Oncol Pharm Pract· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab.
Hannah Dzimitrowicz, Michael Berger, Craig Vargo, Annette Hood, Osama Abdelghany

J Clin Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Occurrence and characterization of everolimus adverse events during first and subsequent cycles in the treatment of metastatic breast cancer.
Craig A Vargo, Michael J Berger, Gary Phillips, Ewa Mrozek

Support Care Cancer· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful Completion of Adjuvant Chemotherapy in a Patient With Colon Cancer Experiencing 5-Fluorouracil-Induced Cardiac Vasospasm.
Craig A Vargo, Marlo Blazer, Joshua Reardon, Martha Gulati, Tanios Bekaii-Saab

Clin Colorectal Cancer· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.
Michael J Berger, Craig Vargo, Mary Vincent, Katy Shaver, Gary Phillips

Support Care Cancer· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An antimicrobial stewardship program's real-world experience with fidaxomicin for treatment of Clostridium difficile infection: a case series.
Craig A Vargo, Karri A Bauer, Julie E Mangino, Jessica E W Johnston, Debra A Goff

Pharmacotherapy· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible correlation of sirolimus plasma concentration with sinusoidal obstructive syndrome of the liver in patients undergoing myeloablative allogeneic hematopoietic cell transplantation.
Patrick J Kiel, Craig A Vargo, Gourang P Patel, Lindsay L Rosenbeck, Shivani Srivastava

Pharmacotherapy· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylaxis with sirolimus and tacrolimus ± antithymocyte globulin reduces the risk of acute graft-versus-host disease without an overall survival benefit following allogeneic stem cell transplantation.
Lindsay L Rosenbeck, Patrick J Kiel, Iftekhar Kalsekar, Craig Vargo, John Baute

Biol Blood Marrow Transplant· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors.
Lokesh Jain, Craig A Vargo, Romano Danesi, Tristan M Sissung, Douglas K Price

Mol Cancer Ther· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis